Bayer backs off Teva's premature Yaz copy

Bayer withdrew its patent lawsuit against Teva Pharmaceutical Industries for allegedly infringing Bayer's Yaz contraceptive with its Gianvi generic, according to court documents. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.